Revance Therapeutics shares owned by Moore Capital Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Moore Capital Management
from 13F filings
Historical chart of Moore Capital Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Moore Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $643k | 250k | 2.57 |
| 2024-03-31 | $1.2M | 250k | 4.92 |
| 2023-12-31 | $1.3M | 150k | 8.79 |
| 2023-09-30 | $1.8M | 160k | 11.47 |
| 2023-06-30 | $1.4M | 55k | 25.31 |
| 2014-06-30 | $3.4M | 100k | 34.00 |